Compare Indofarma Tbk. (INAF) vs Tanah Laut Tbk (INDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indofarma Tbk. vs Tanah Laut Tbk — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Tanah Laut Tbk trades at Rp60 (market cap 26.27B). The key difference: Indofarma Tbk. is far larger — about 14.9× Tanah Laut Tbk's market cap. Which is the better fit depends on your goals.
| INAF | INDX | |
|---|---|---|
Market Cap | 390.51B | 26.27B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →About Tanah Laut Tbk
PT Tanah Laut Tbk formerly PT Indoexchange Tbk (the Company) was established under the name PT Sanggrahamas Dipta based on Notarial Deed No.78 dated September 19, 1991 of Rahmah Arie Sutarjo, S.H., notary in Jakarta. The Company changed its status from Foreign Capital Investment Company to Domestic Capital Investment Company, approved by the Chairman of Capital Investment Coordinating Board in accordance with Approval Letter No. 38/V/PMDN/2008 dated September 23, 2008.
Read more on INDX →
